Identification of Novel Tumor Suppressor Long Non-coding RNAs epigenetically silenced in Hepatocellular Carcinoma
Project Name in Chinese
肝癌中表達沉默的新的長鏈非編碼RNA(lncRNA)的鑒別及功能分析
Brief description of the Project
---
Academic Discipline of the Research Project
Basic medicine
Academic Discipline (specifically) in Chinese
1001 基礎醫學
Is this an inter-disciplinary project ?
---
Discipline 1)
---
Academic Discipline (specifically) in Chinese
---
Discipline 2)
---
Academic Discipline (specifically) in Chinese
---
Special Requirement for the Postdoctoral Fellow Candidates(if any)
---
Academic Qualifications
2005 Postdoctoral Fellow
University of Washington, Seattle, USA
2003 Ph.D. Zhongshan Medical College, Sun Yat-Sen University, China
2000 M.Phil. Guangdong Medical College, China
1997 Hunan Medical University, China
Professional Accomplishments, Honors, Awards and Patents
1. The recipient of a grant amounting to 100,000 US dollars in the second round of Grand Challenges Explorations in 2009 from The Bill & Melinda Gates Foundation. One of the 81 receipts out of more than 3,000 applicants worldwide including North America and Europe.
2. Young Investigator Award, American Pancreatic Association & International Association of Pancreatology, October 2012.
3. Young Investigator Award, International Digestive Diseases Forum, 2013.
4. Collaborative Research Award, The Chinese University of Hong Kong, 2014.
5. Outstanding Young Investigator Award, Pancreatic Cancer Committee, Chinese Anti-cancer Association, 2016.
Are you a member of the Society of Hong Kong Scholars?
Yes
Research direction and research fund
Major Research Interests
1. Gastrointestinal cancer including pancreatic cancer and liver cancer;
2. Long and short non-coding RNAs;
3. Role of EZH2 in cancer
4. Identification of novel cancer-associated genes using large scale genetic perturbation screen such as CRISPR/CAS9;
5. Development of novel therapeutics for cancer
Number of Current PhD Students
3
Number of PhD Trained
5
Number of Postdoctoral Fellows Supervised
5
Active Research Grants in the Capacity of PI
1. Identification of novel tumor suppressor long non-coding RNAs epigenetically silenced in hepatocellular carcinoma. Research Grants Council General Research Fund (GRF), 2017-2020, HK$: 1,000,716, Capacity: PI.
2. Metabolism and pharmacokinetic analysis of a small molecule modulator of tumor suppressor microRNA-34a. Innovation and Technology Fund, 2015-2017, HK$: 1,398,664. Capacity: PI.
3. Characterization of a novel long non-coding RNA AK311005 with potential tumor suppressive role in pancreatic ductal adenocarcinoma. Research Grants Council General Research Fund (GRF), 2015-2018, HK$: 763,494, Capacity: PI.
4. Identification and functional characterization of long non-coding RNAs associated with pancreatic ductal adenocarcinoma. Research Grants Council General Research Fund (GRF), 2014-2017, HK$: 1,299,049, Capacity: PI.
5. Regulation and function of histone demethylase JMJD3 in HBV-induced hepatocarcinogenesis. Health and Medical Research Fund (HMRF), 2013-2015, HK$: 780,128, Capacity: PI.
6. Functional characterization of EZH2/miR-218 interaction in pancreatic ductal adenocarcinoma. Research Grants Council General Research Fund (GRF), 2012-2015, HK$: 862,500, Capacity: PI.
7. Identification of novel therapeutic targets for pancreatic cancer by genome-wide RNAi screening in vivo. National Natural Science Foundation of China (NSFC), 2017-2020, RMB: 570,000.
8. Investigation on the anti-cancer activity against liver cancer and the underlying mechanism of small molecule modulator of microRNA-34a. National Natural Science Foundation of China (NSFC), 2015-2019, RMB: 760,000.
9. Functional characterization of Hepatitis B viral X protein/microRNA-21 interaction in HBV associated hepatocellular carcinoma. Research Fund for the Control of Infectious Disease, 2012-2014, HK$: 1,000,000, Capacity: PI.